Method to treat smoking withdrawal symptoms by potentiated centr

Details Method to treat smoking withdrawal symptoms by potentiated centr Method to treat smoking withdrawal symptoms by potentiated centr

1988-02-29

1988-11-29

Friedman, Stanley L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514255, 514401, 514538, 514540, 514813, A61K 3124, A61K 3154, A61K 31415, A61K 31495

Patent

active

047881895

ABSTRACT:
Administering divided dose of oral Clonidine potentiated by an intramuscular tricyclic antidepressant alleviates the abstinence syndrome resulting from withdrawal of nicotine by smoking cessation. Patient response to the Clonidine/tricyclic serves as the basis for titrating the dosages of transdermal Clonidine and oral buspar administered daily for two weeks following the office visit. Behavioral counseling, supported by written and audio materials on diet, nutrition, exercise, stress management, and habit control, are provided to the patient. Following up support groups are also made available.

REFERENCES:
patent: 4575510 (1986-03-01), Sjoerdsma
patent: 4588739 (1986-05-01), Glassman
Chem. Abst. 106-97867f, (1987).

Affiliated with

Also associated with

Rating

Method to treat smoking withdrawal symptoms by potentiated centr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method to treat smoking withdrawal symptoms by potentiated centr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to treat smoking withdrawal symptoms by potentiated centr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-363634